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Abstract
This prospective observational study investigated monocyte cytokine responses to lipopolysaccharide (LPS) in
patients with obstructive jaundice (OJ) before and after endoscopic biliary drainage. Dendritic cell (DC) subsets and
their expression of co-stimulatory molecules were also studied. Forty patients with OJ and ten non-jaundiced
patients with normal gastroscopy findings were recruited. Ten healthy volunteers provided control blood samples for
immunological assays. Patients with OJ had blood and duodenal mucosa sampled at the time of endoscopic
retrograde cholangiopancreatography (ERCP) and further blood sampled during the recovery phase. Monocyte
cytokine responses to LPS, DC subsets and co-stimulatory molecule expression were compared with controls.
Duodenal morphology and occludin expression were also assessed. Monocytes obtained before ERCP from
jaundiced patients demonstrated reduced cytokine responses to endotoxin compared with controls (IL-1β: 2678
compared with 4631 pg/ml, P= 0.04 and IL-6: 3442 compared with 6157 pg/ml, P= 0.002). Monocytes from
patients with malignancy had poorer responses to endotoxin than from those with benign OJ (IL-1β: 2025 compared
with 3332 pg/ml, P= 0.001). After ERCP, the secretion of inflammatory cytokines by monocytes obtained from
jaundiced patients increased (IL-1β: 2150 compared with 2520 pg/ml, P= 0.03 and IL-6: 2488 compared with
3250 pg/ml, P= 0.01). Occludin expression (85 compared with 95%, P= 0.004) and mean duodenal villus height
(334 compared with 404 μm, P= 0.03) were lower in jaundiced patients. Before biliary drainage, patients with OJ
had a higher percentage of myeloid dendritic cells (mDCs) and greater mDC expression of CD40 (P= 0.04) and
CD86 (P= 0.04). Monocytes from patients with OJ had lower proinflammatory cytokine secretion in response to
LPS, an effect reversed following biliary drainage.
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INTRODUCTION
Patients with obstructive jaundice (OJ) are at a higher risk of
perioperative complications than those without jaundice [1–3].
They are susceptible to infection and renal impairment, and des-
pite advances in critical care and antimicrobial therapy, mortality
rates remain high [4,5]. Although the underlying mechanisms
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for this elevated risk are not fully understood, evidence suggests
that OJ may allow translocation of bacteria or bacterial products
into the portal and, subsequently, systemic circulations which
might result in chronic activation of immune cells in response
to endotoxin exposure. The evidence supporting this hypothesis
has come mainly from animal models as it is difficult to sample
portal blood or lymphoid tissue in humans [6,7]. These studies
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confirm impaired intestinal integrity, and translocation of enteric
bacteria and bacterial products to mesenteric lymph nodes in
the presence of biliary obstruction [6,8]. Diminished capacity
of Kupffer cells to clear bacteria or endotoxin from the portal
circulation is observed and these effects may contribute to the
development of low-grade systemic inflammation which might
impair anti-microbial immunity and lead to sepsis or multiple
organ dysfunction [9,10]. Bacterial translocation to mesenteric
lymph nodes has been demonstrated following laparotomy and
in patients with OJ this is associated with a higher rate of post-
operative complications [11].
Endotoxin tolerance (ET) is defined as a transient hypore-
sponsiveness of the host’s immune cells to repeated or prolonged
exposure to low doses of lipopolysaccharide (LPS) [12]. Origin-
ally observed in animals pretreated with low dose LPS, ET is
characterized by decreased production of the proinflammatory
cytokines tumour necrosis factor-alpha (TNF-α), interleukin-1
beta (IL-1β) and IL-6, as well as lower mortality rates follow-
ing repeated challenge with LPS [13,14]. Studies in both healthy
volunteers and patients with sepsis have provided evidence for
ET in humans [15–17]. Monocytes obtained from patients with
sepsis demonstrated a reduced capacity for secretion of TNF-α,
IL-1β and IL-6 following ex vivo stimulation with LPS [18–
22]. Conversely, LPS-stimulated monocytic secretion of IL-10
and transforming growth factor-beta (TGF-β) from septic pa-
tients remain unaffected, indicating that these cells are still able
to respond to LPS but that this response has been altered with a
polarization of the T helper (Th) cell profile [23,24]. Dendritic
cells (DCs), macrophages and neutrophils have been shown to
mirror the tolerance responses of monocytes [25,26]. DCs as key
antigen presenting cells, may contribute further to tolerance by
driving Th1 responses to a Th2 pattern [27].
It is recognized that inflammatory cascades left unchecked
can cause widespread organ dysfunction and ultimately death.
ET may be a mechanism to curb this response and induce an anti-
inflammatory phenotype with repeated exposure to endotoxin.
Hence, ET may contribute to the increased susceptibility to post-
operative septic complications seen in patients with OJ.
The aims of this study were to:
• seek evidence of ET in patients with OJ by investigating the
capacity of monocytes to generate inflammatory cytokines and
the effect of relieving the jaundice by ERCP.
• examine the changes in DC subsets expression of co-
stimulatory molecules and alterations in intestinal mucosal
architecture in the presence of OJ due to benign and malig-
nant disease.
• study mechanisms rather than outcomes of these phenomena.
MATERIALS AND METHODS
Study design and setting
This was a prospective observational study in 40 patients with
OJ before and after endoscopic biliary drainage to examine ex
vivo monocyte responses while jaundiced and during the recov-
ery phase. These were compared with monocyte responses from
blood samples obtained from 10 healthy volunteers. Participants
were recruited at Nottingham University Hospitals NHS Trust.
Ethics and consent
The study was granted approval by the UK National Re-
search Ethics Service and the protocol was registered at
http://www.clinicaltrials.gov (NCT01367821). Informed written
consent was obtained from all participants.
Selection criteria for study groups
There were four study groups.
Groups 1 and 2
Groups 1 and 2 comprised patients with OJ scheduled to un-
dergo ERCP, with 20 patients having malignant biliary obstruc-
tion (Group 1) and 20 benign biliary obstruction (Group 2).
Inclusion criteria: male or female patients, aged 18–75 years,
with evidence of OJ and a serum bilirubin >30 μmol/l.
Exclusion criteria: neutropenia (<1.5 × 109/l), smokers/
substance abusers, patients with diabetes, taking corticosteroids,
on antibiotics, with active biliary sepsis, who had undergone or-
gan transplantation, with pancreatic pseudocysts, patients with
haematological malignancies and any patient who had incom-
plete biliary drainage or failure of ERCP. Patients were withdrawn
from the study if they became critically ill (defined as APACHE
II Score 8) at any time.
Group 3
Ten non-jaundiced patients undergoing oesophagogastroduoden-
oscopy (OGD) for the investigation of upper gastrointestinal
symptoms were recruited to only provide control duodenal mu-
cosal specimens. Patients were excluded if any abnormalities
were found at OGD.
Group 4
Ten healthy adult volunteers were recruited to provide control
blood samples for monocyte assays. Volunteers with any acute
illness in the preceding 6 weeks, on any regular medication and
those with a history of smoking/substance abuse were excluded.
Interventions
All patients with OJ underwent treatment of the obstruction at
ERCP by stone extraction or stent placement. Non-jaundiced pa-
tients underwent OGD. End points studied before and after drain-
age of bile included serum bilirubin, alanine aminotransferase
(ALT), alkaline phosphatase (ALP), white cell count (WCC), C-
reactive protein (CRP) concentration, blood monocyte cytokine
responses following stimulation with LPS, changes in DC sub-
sets and myeloid (m) mDC co-stimulatory molecule expression.
One-off endpoints included culture of bile, duodenal villus height
and occludin expression.
Sample collection and immunological assays
An 80 ml blood sample was obtained from patients with OJ prior
to ERCP and used for immunological assays and the measurement
of haematological and biochemical parameters. Additional 80 ml
blood samples were collected on days 1, 7, 14 and 30 following
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Table 1 Groups and baseline characteristics of patients in OJ study. Values presented are n or mean (S.E.M.)
*: P< 0.05 (benign compared with malignant); †: P< 0.05 (malignant compared with non-jaundiced).
Benign obstruction Malignant obstruction Non-jaundiced controls Healthy volunteers
Number of subjects 20 20 10 10
Age (years) 51 (4) 64 (2)*,† 47 (1) 36 (1)
Gender (male:female) 9:11 12:8 3:7 6:4
Bilirubin (μmol/l) 151 (16) 196 (24)* – –
ALT (IU/l) 63 (7) 112 (11)* – –
ALP (IU/l) 106 (14) 164 (17)* – –
WCC (×109/l) 12.8 (1.3) 10.5 (0.9) – –
CRP (mg/l) 50 (9) 62 (10)* – –
Diagnoses/reasons for
endoscopy
Choledocholithiasis: 18 Pancreatic cancer: 12 Dyspepsia: 4
Benign CBD stricture: 1 Periampullary cancer: 4 Epigastric pain: 4
Benign CBD polyp: 1 Malignant CBD stricture: 4 Dysphagia: 2
biliary drainage. If patients were to undergo a further intervention
or surgery prior to the 30-day blood sample, the final sampling
time point was brought forward. A similar 80 ml blood sample
was drawn once from each healthy volunteer but not from non-
jaundiced patients undergoing OGD.
Mononuclear cells were isolated from whole blood and mono-
cytes purified using immunomagnetic separation. Monocytes
were isolated at intervals after drainage to assess the time course
of responses. During a stimulation period of 24 h at 37 ◦C, mono-
cytes were exposed to differing concentrations of LPS (1, 10
and 100 ng/ml) and cytokine secretion (IL-β, IL-6, IL-10 and
IL-1RA) was assessed by flow cytometry (Beckmann Coulter,
FC500 MPL, Fullerton). Purified monocytes were then stimu-
lated with different concentrations of LPS and incubated at 37 ◦C
for 24 h (tstim).
To characterize DC subsets, PBMCs were isolated from pa-
tients at each sampling time point. Details for these techniques
are described in the Supplementary Methods section.
Bile and duodenal sampling
At the time of ERCP, the common bile duct (CBD) was cannulated
(without priming with saline or radiocontrast) and a bile sample
was aspirated through a sterile catheter and collected into a sterile
universal pot. Two duodenal biopsies were taken during ERCP
from patients with OJ and non-jaundiced patients undergoing
OGD for investigation of upper GI symptoms. The first sample
was collected in a sterile container with formalin and the second
in a sterile container with sterile water.
Aliquots of bile (100 μl) were cultured on blood agar (BBL,
Microbiology Systems) and MacConkey agar (Thermo Fisher
Scientific). All plates were examined after 24–48 h of aerobic
incubation at 37 ◦C then daily for 7 days for anaerobic culture.
Duodenal biopsies obtained at ERCP from patients with OJ and
non-jaundiced controls at OGD were processed to measure mu-
cosal thickness, villus height, crypt depth and occludin expression
in a blinded manner (Supplementary Methods).
Statistical analysis
Statistical analysis was performed using the GraphPad Prism
v6.0 software (GraphPad Software) using a repeated measures
ANOVA design. Data were subjected to D’Agostino and Pearson
omnibus normality tests to determine normality of distribution.
As the results were distributed normally, data were analysed with
the Student t test. Correlation was assessed with Pearson’s coef-
ficient of correlation and categorical data were analysed with
the Chi-square test. Differences were considered significant at
P< 0.05.
RESULTS
Demographics
The demographic profile of the participants is shown in Table 1.
Seven patients [five with malignant OJ (three disease-related
deaths, two became critically ill); two with benign OJ (became
critically ill)] did not complete the study. All patients with ma-
lignant OJ had biliary stents placed at ERCP. CBD calculi were
extracted in 12 patients with benign OJ, and 8 had biliary stents
placed.
Changes in serum bilirubin, liver enzymes and
inflammatory markers in patients with benign and
malignant obstruction after drainage
Mean concentrations of serum bilirubin, ALT and ALP were
elevated above the reference laboratory ranges in both groups
(Figure 1). Although serum bilirubin concentrations were signi-
ficantly higher in patients with malignant OJ prior to drainage,
there was no significant difference between groups after drain-
age. Both ALT and ALP were higher prior to drainage in patients
with malignant OJ compared with those with benign OJ and this
difference in concentrations of both enzymes between groups re-
mained after drainage. At the time of recruitment there was a
slight, albeit non-significant, elevation in WCC above the normal
reference range in patients with benign OJ (Figure 1). In addi-
tion, serum CRP concentrations were initially elevated in both
groups and reduced significantly after drainage (Figure 1). How-
ever, there were no significant differences between patients with
benign and malignant OJ in either WCC or CRP.
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Figure 1 Liver function tests and inflammatory markers
Assessment of serum bilirubin, ALT, ALP, WCC and CRP in blood samples from patients undergoing ERCP for OJ. Values
presented are mean (S.E.M.). Given P values represent test of overall data (repeated measures ANOVA comparing benign
with malignant obstruction); *: P< 0.05 (Student t test) for comparison of patients with benign compared with malignant
biliary obstruction.
Monocyte cytokine responses following stimulation
with LPS
Overall cytokine responses to stimulation with LPS were reduced
significantly for IL-1β and IL-6 in patients with OJ compared
with healthy volunteers (Figure 2). Prior to biliary drainage, pro-
duction of IL-6 by monocytes was reduced significantly in pa-
tients with malignant OJ compared with monocytes from patients
with benign OJ (P= 0.002). Similar results were observed for
stimulation at a concentration of 10 and 100 ng/ml LPS. Mono-
cyte production of IL-10 and IL-1RA was unaffected either before
or after biliary drainage and there were no differences between
patients with benign and malignant OJ for these cytokines. The
capacity for IL-1β and IL-6 production recovered in both the
benign and malignant patient groups during the post-drainage
period. There was an inverse relationship between serum biliru-
bin concentrations and monocyte cytokine secretion of IL-1β and
IL-6, but this correlation was not statistically significant follow-
ing Pearson’s test.
Changes in DC numbers following endoscopic
biliary drainage
Prior to biliary drainage, patients with both benign and malignant
biliary obstruction had a higher percentage of myeloid dendritic
cells (mDCs) compared with blood samples obtained from 10
healthy controls (P< 0.05) (Figure 3). However, there was no
significant difference between patients with benign and malignant
OJ. Following drainage there was a fall in the number of mDCs
in patient samples. Compared with healthy volunteers, there was
a greater percentage of circulating DCs expressing the activation
markers CD40 (P= 0.04) and CD86 (P= 0.04) for both patient
groups and this higher expression was not affected by biliary
drainage (Figure 3).
Analysis of bacterial organisms in bile
Bile cultures taken at the time of ERCP were analysed for bac-
terial growth. There was no significant difference in the rate of
positive bile cultures (Table 2) between the benign and malignant
OJ groups (P= 0.50).
Occludin expression and villus height
Duodenal biopsies taken at the time of ERCP in patients with
jaundice demonstrated significant reductions in villus height and
occludin expression when compared with controls (Figure 4).
However, there were no significant differences in villus height
and occludin expression between specimens obtained from pa-
tients with benign and malignant jaundice (Figure 4). There was
evidence of chronic inflammation in the duodenal biopsies from
patients with jaundice which was not seen in specimens obtained
from control patients without jaundice.
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Figure 2 Cytokine responses
Flow cytometric assessment of cytokine secretion using the bead array technique following in vitro exposure of purified
monocytes to 1, 10 and 100 ng/ml LPS for 24 h. Values presented are mean (S.E.M.). HV: healthy volunteers; U: untreated
cells. *: P< 0.05; **: P< 0.01 (Student t test) for comparison of patients with benign compared with malignant biliary
obstruction. When incubated with LPS at a concentration of 100 ng/ml, monocytes obtained before ERCP from jaundiced
patients demonstrated reduced cytokine responses to endotoxin compared with controls (IL-1β: 2678 compared with
4631 pg/ml, P = 0.04 and IL-6: 3442 compared with 6157 pg/ml, P = 0.002). Monocytes from patients with malignancy
had poorer responses to endotoxin than from those with benign OJ (IL-1β: 2025 compared with 3332 pg/ml, P = 0.001).
After ERCP, the secretion of inflammatory cytokines by monocytes obtained from jaundiced patients increased (IL-1β: 2150
compared with 2520 pg/ml, P = 0.03 and IL-6: 2488 compared with 3250 pg/ml, P = 0.01).
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Figure 3 Dendritic cells and co-stimulatory molecules
Number of DCs (left) and expression of co-stimulatory molecules CD40 (centre) and CD86 (right) in blood samples from
patients with OJ. DCs were selected by flow cytometry using a gate based on HLA-DR+Lin1−. The mDC population was then
selected from a gate demonstrating CD11c+CD1c+. The co-stimulatory molecules CD40 and CD86 were both selected
using the gates SSC+CD40+ and SSC+CD86+ respectively. Values presented are mean (S.E.M.). HV: healthy volunteers.
P> 0.05 (repeated measures ANOVA) for comparison of patients with benign compared with malignant biliary obstruction.
P< 0.05 for comparison of healthy volunteers compared with patients with OJ.
Table 2 Summary of bile culture results in benign and
malignant OJ patients
Number of positive bile cultures (%)
Benign
obstruction
Malignant
obstruction
Escherichia coli 4 (20) 3 (15)
Klebsiella spp. 2 (10) –
Enterobacter spp. – 1 (5)
Pseudomonas aeruginosa 1 (5) –
Enterococcus faecalis 1 (5) –
Streptococcus viridians – 1 (5)
Total 8 (40) 5 (25)
DISCUSSION
This study has demonstrated that OJ is associated with dimin-
ished monocyte proinflammatory cytokine secretion following
exposure to LPS in vitro, when compared with healthy controls.
In addition, we have shown that monocyte proinflammatory cy-
tokine responses were restored following the relief of biliary
obstruction. We have also demonstrated an increased percentage
of cells expressing the co-stimulatory molecules CD40 and CD86
on DCs obtained from patients with OJ. A diminished capacity
to generate proinflammatory Th1 cytokine responses to bacteria
or their products may explain the susceptibility of these patients
to perioperative septic complications. Furthermore, demonstra-
tion of altered intestinal mucosal architecture in patients with OJ
supports the likelihood of bacterial translocation and its potential
effects on host immunity and susceptibility to infection.
Compared with monocytes obtained from healthy donors, pa-
tients with OJ had a reduced capacity to produce proinflammat-
ory cytokines in response to LPS. This was most evident for
LPS concentrations of 100 ng/ml, but for IL-1β and IL-6, lower
LPS concentrations produced a similar result. In contrast, in vitro
monocyte production of IL-10 and IL-RA in response to LPS
was unaffected, indicating that suppression was restricted to the
generation of proinflammatory cytokines.
One possible mechanism to explain suppression of proinflam-
matory cytokine production in OJ could involve ET. The clinical
implications of this in OJ have not been investigated thus far,
but in other conditions such as cystic fibrosis and acute pulmon-
ary syndromes, ET is associated with an increased susceptibility
to nosocomial infections [28]. Although ET may protect against
septic shock and ischaemia, it is associated with a high incid-
ence of secondary infections. Primary exposure to bacteria or
their products during a period of OJ may render immune cells
‘tolerized’ to secondary exposures and limit the magnitude of
subsequent cytokine responses, thereby favouring the survival of
potential pathogens.
Most studies investigating ET have demonstrated the reduced
production of IL-6 and TNF-α [29]. Our results indicate that the
proinflammatory cytokine IL-1β may also be affected. Tolerance
to endotoxin-stimulated expression of IL-1β has been shown in
neutrophils [30] and monocytes [31].
In the present study there was no significant suppressive
effect of LPS exposure on monocyte production of the anti-
inflammatory cytokine IL-10. Cells obtained from healthy sub-
jects showed a marked increase in secretion of IL-10 compared
with untreated cells. Some studies have shown impaired pro-
duction of IL-10 after previous exposure to LPS [29], whereas
others have documented up-regulation of IL-10, TGF-β and IL-
1RA [32]. In murine studies, small doses of LPS are lethal in
knockout mice unable to transcribe the IL-10 gene [32] and it has
been proposed that the IL-10-mediated suppression of TNF-α,
IL- 1, IL-6, IL-8 and granulocyte-macrophage colony-stimulating
factor by human monocytes may confer a protective effect. Sub-
sequent clinical studies in sepsis have demonstrated the associ-
ation of ET with high levels of circulating IL-10 and low levels
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Figure 4 Duodenal morphology
Villus height (μm) (top) and occludin expression (%) (bottom) in duo-
denal biopsies from patients with benign and malignant OJ and non–
jaundiced patients with normal gastroscopy findings. For each patient,
10 randomly chosen mucosal regions were traced using an electromag-
netic stylus and villus height measured. For each part of the villus a
percentage value of occludin expression was obtained by dividing the
number of occludin positive enterocytes by the total number of entero-
cytes. Values presented are mean (S.E.M.). *: P< 0.05 (Student t test).
of monocyte human leucocyte antigen - D related (HLA-DR)
expression [33].
Patients with malignant biliary obstruction had significantly
lower cytokine responses following LPS exposure compared with
patients with benign obstruction. In previous studies, higher con-
centrations of circulating proinflammatory cytokines have been
found in patients with malignant obstruction compared with those
with benign disease, correlating with elevated acute phase react-
ants as well as the duration of the jaundice [34,35]. In the few
studies that examined circulating cytokine concentrations in pa-
tients with OJ undergoing ERCP, low concentrations of IL-6 and
TNF-α were observed following drainage [34,36]. The results
of the present study indicate that cytokine responses in patients
with malignant OJ were impaired to a greater extent when com-
pared with those with benign OJ. The capacity of Kupffer cells
to clear LPS may be impaired in the presence of OJ [9,37,38],
thus exposing immune cells to higher concentrations of LPS and
for prolonged periods. This prolonged exposure to LPS with im-
paired Kupffer cell function may be one possible mechanism for
the differences observed between benign and malignant groups.
Although differences in monocyte cytokine responses were
evident between the benign and malignant groups, there were no
significant differences in DC phenotype. Compared with healthy
volunteers, patients with OJ had a greater proportion of DCs
expressing the CD11c cell surface glycoprotein, indicating a pre-
dominance of the mDC lineage. Following endoscopic biliary
drainage, the proportion of mDCs fell but this was similar in
both benign and malignant groups. Previous murine studies have
examined the effect of bile duct ligation on liver DC subsets
and found a 15-fold expansion of the myeloid lineage [39]. The
magnitude of mDC lineage expansion was not of the same or-
der in the present study, although compared with cells obtained
from healthy subjects, the proportion of DCs with the CD11c cell
surface marker was significantly higher.
On examining co-stimulatory molecule expression on
CD11c+ cells obtained from patients with OJ, both CD40 and
CD86 markers were expressed at higher levels compared with
cells obtained from healthy subjects. In murine studies, BDL did
not affect the maturation status of DCs [39]. Surface expression
of MHC class II, CD40, CD80 and CD86 were similar at 3, 7
and 14 days after BDL, and the ability to induce the proliferation
of allogeneic and syngeneic T cells was higher compared with
controls [39]. The authors suggested that exposure to LPS may
explain this finding as 75 % of the mice with bile duct ligation
were eventually found to have bacteriobilia.
In the present study, patients with malignant biliary obstruc-
tion were significantly more jaundiced than those with benign
obstruction prior to intervention. Following ERCP and biliary
drainage, however, bilirubin concentrations fell in both groups to
reach comparable values. There were no observed differences in
degrees of inflammation between malignant and benign groups,
as assessed by WCC and CRP. Elevations of WCC and CRP
in OJ may be a reaction to bacteraemia occurring after instru-
mentation or contrast injection, and has been demonstrated previ-
ously [40]. Bacteraemia following ERCP is associated rarely with
clinical manifestations of sepsis, occurring in only 0.4–0.8 % of
procedures [41].
In the present study, bacterial growth in bile obtained at ERCP
was seen in one third of the patients with OJ, with those with
benign obstruction having a slightly higher level of positive cul-
tures, similar to other studies [42,43]. Although it is presumed
that organisms ascend to infect static bile, it is also possible that
organisms could translocate from the gut into the portal circula-
tion and reach bile through the liver.
Bile exerts trophic effects on the intestinal mucosa, increasing
villus density and hypertrophy of intestinal wall components [44].
Recent work has shown a pivotal role of bile in the maintenance
of enterocyte tight junctions and the expression of tight junction-
associated proteins [44–46]. Weakened integrity of intestinal mu-
cosa could allow passage of bacteria or bacterial products into
the portal circulation and our findings could be the consequence
of increased exposure to LPS. The results of the present study in-
dicate that OJ induces intestinal morphological changes, such as
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reduction in villus height and disruption of mucosal architecture.
Furthermore, OJ is associated with decreased expression of duo-
denal occludin compared with non-jaundiced controls. No differ-
ences were observed between patients with benign and malignant
OJ in either villus height or occludin expression, despite higher
bilirubin concentrations in the malignant group. These results
are consistent with previous studies in both animals [45,47] and
humans [46,48], showing decreased expression of tight-junction
proteins in the absence of intestinal bile, which can be reversed
once OJ is relieved.
Some limitations of this study warrant discussion. In the study
of cytokine responses, the mean age of control subjects was lower
than those with disease. It is possible that age-related changes
could account for some of the observed differences. However,
studies examining the influence of age on proinflammatory cy-
tokine secretion point to an increase in responsiveness to bac-
terial products with advancing age [49–51]. It might be inferred,
therefore, that the differences in cytokine secretion in the present
study would likely be wider if control and disease groups were
age matched. The changes in cytokine responses have been de-
termined by one modality and it is not clear whether OJ affects
receptor function, cytokine expression or secretion. Recently an
IL-1R-associated kinase (IRAK-M) has been characterized which
acts as a negative regulator in toll like receptor-4 signalling. The
significance of this protein is illustrated by the lack of ET in
IRAK-M deficient mice [52] and it has been demonstrated that
IRAK-M concentrations negatively correlate with the production
of TNF-α by mononuclear cells in patients with OJ [53].
In summary, patients with OJ have reduced capacity to gener-
ate proinflammatory cytokine responses in vitro compared with
healthy controls and have changes in intestinal mucosal archi-
tecture compared with non-jaundiced individuals. These changes
may contribute to the elevated risk of septic complications asso-
ciated with surgery in these patients.
CLINICAL PERSPECTIVES
• Patients with OJ have higher rates of perioperative sepsis than
non-jaundiced patients but the mechanisms underlying this
observation remain unclear. ET, which is characterized by the
decreased production of inflammatory cytokines by immune
cells following exposure to LPS, is a mechanism that may
explain this observed elevated risk.
• Compared with healthy individuals, monocytes obtained from
patients with OJ had reduced proinflammatory cytokine secre-
tion in response to exposure to LPS. These cytokine secretory
responses were restored following relief of OJ.
• Understanding mechanisms of immune cell dysfunction in OJ
may indicate potential clinical pathways to reduce the periop-
erative risk of septic complications in these patients.
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